The Liběchov minipigs from the PIGMOD Center of the Institute of Animal Physiology and Genetics CAS were used in the pre-clinical testing of a new therapy for Huntington’s disease, a serious human disorder affecting the brain. The outcoming promising results have paved the way for the therapy to enter the clinical trial phase, bringing the actual treatment options for this disease closer to patients in Europe.